Իտալիա - անգլերեն - HMA (Heads of Medicines Agencies)

pfizer limited - feline leukaemia virus 8.1 log2 - suspension for injection - cats non food - feline leukaemia virus

Պորտուգալիա - անգլերեն - HMA (Heads of Medicines Agencies)

pfizer limited - feline leukaemia virus 8.1 log2 - suspension for injection - cats non food - feline leukaemia virus

Ռումինիա - անգլերեն - HMA (Heads of Medicines Agencies)

pfizer limited - feline leukaemia virus 8.1 log2 - suspension for injection - cats non food - feline leukaemia virus

Սլովենիա - անգլերեն - HMA (Heads of Medicines Agencies)

pfizer limited - feline leukaemia virus 8.1 log2 - suspension for injection - cats non food - feline leukaemia virus

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - feline leukaemia virus - inactivated - vaccine or antisera - feline leukaemia virus - inactivated vaccine-viral active 0.0 u - immunotherapy

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - feline leukaemia - unknown - feline leukaemia vaccine active 0.0 - active constituent

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - inactivated feline leukaemia virus(felv) subtypes a, b and c - suspension for injection - . - feline leukaemia virus - cats - immunological - inactivated vaccine

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

virbac s.a. - feline leukemia virus envelope antigen p45 - suspension for injection - %v/v - feline leukaemia virus vaccine - feline - immunological - inactivated vaccine

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - recombinant omega interferon of feline origin - parenteral liquid/solution/suspension - recombinant omega interferon of feline origin vaccine active 10.0 mu/ml - immunotherapy - cat | dog - adult | cat - queen | cat - tom | kitten - canine parvovirus | feline calicivirus | calicivirus (feline) | fcv | parvovirus

Եվրոպական Միություն - անգլերեն - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.